Armando Bartolazzi

Department of Pathology, Sant’Andrea University Hospital, Rome, Italy

About this speaker

The Speaker is updating their bio. Please check back here later.

Talks

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs

21 September 2021, 09:00 AM
Armando Bartolazzi